GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (OTCPK:CALZF) » Definitions » PB Ratio

Polynovo (Polynovo) PB Ratio

: 19.25 (As of Today)
View and export this data going back to . Start your Free Trial

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-19), Polynovo's share price is $1.29. Polynovo's Book Value per Share for the quarter that ended in Dec. 2023 was $0.07. Hence, Polynovo's PB Ratio of today is 19.25.

The historical rank and industry rank for Polynovo's PB Ratio or its related term are showing as below:

CALZF' s PB Ratio Range Over the Past 10 Years
Min: 2.26   Med: 16.38   Max: 109.72
Current: 18.43

During the past 13 years, Polynovo's highest PB Ratio was 109.72. The lowest was 2.26. And the median was 16.38.

CALZF's PB Ratio is ranked worse than
97.36% of 795 companies
in the Medical Devices & Instruments industry
Industry Median: 2.15 vs CALZF: 18.43

During the past 12 months, Polynovo's average Book Value Per Share Growth Rate was 5.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 38.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 8.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 11.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Polynovo was 38.20% per year. The lowest was -49.30% per year. And the median was -9.65% per year.

Back to Basics: PB Ratio


Polynovo PB Ratio Historical Data

The historical data trend for Polynovo's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polynovo Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PB Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.74 75.60 76.92 52.63 21.09

Polynovo Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.27 52.63 18.59 21.09 11.94

Competitive Comparison

For the Medical Devices subindustry, Polynovo's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polynovo PB Ratio Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Polynovo's PB Ratio distribution charts can be found below:

* The bar in red indicates where Polynovo's PB Ratio falls into.



Polynovo PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Polynovo's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=1.29/0.067
=19.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Polynovo  (OTCPK:CALZF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Polynovo PB Ratio Related Terms

Thank you for viewing the detailed overview of Polynovo's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Polynovo (Polynovo) Business Description

Traded in Other Exchanges
Address
320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207
Polynovo earns most of its revenue from U.S. sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.

Polynovo (Polynovo) Headlines

From GuruFocus

Polynovo Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Full Year 2022 Polynovo Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Half Year 2022 Polynovo Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Investor Update Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Extraordinary Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-13-2024